soul trial oral semaglutide cardiovascular outcomes results 2025 shows has positive CV benefits in type 2 diabetes SOUL (Semaglutide cardiOvascular oUtcomes triaL)

However, we also estimate longer run effects in a smaller sample and find no cost offsets even five years after GLP-1 initiation Medicare implications MA may need an upward benchmark adjustment

No use guidance

The side effects were mild, and Nooms app kept me motivated and educated. Pros Cons Personalized microdose and full-dose options Upfront billing, no live scheduled coaching Lower cost and fewer side effects at microdose Medication costs not always covered Telehealth visits and care team messaging Compounded meds not FDA approved in all states Branded medication prescriptions available Cancellation or insurance can be confusing Labs included (except some states) Not available in AL or VA App-based tracking plus lifestyle coaching Some support issues, especially after sign-up Noom GLP 1 Reviews program aims to minimize typical GLP-1 side effects (nausea, GI upset), with most members reporting little to no occurrence of these issues

Semaglutide base is the form used in FDA-approved medications

Modulatory Effect of Gastric Pentadecapeptide BPC 157 on Angiogenesis in Muscle and Tendon Healing